Skip to main content

and
  1. Article

    Open Access

    Follow-up of men with a PI-RADS 4/5 lesion after negative MRI/Ultrasound fusion biopsy

    Magnetic resonance imaging/Ultrasound (MRI/US) fusion targeted biopsy (TB) in combination with a systematic biopsy (SB) improves cancer detection but limited data is available how to manage patients with a Prosta...

    Kira Kornienko, Miriam Reuter, Andreas Maxeiner, Karsten Günzel in Scientific Reports (2022)

  2. Article

    Open Access

    Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers

    The transcriptional coactivator YAP1 controls the balance between cell proliferation and apoptosis. YAP1 overexpression is linked to poor prognosis in many cancer types, yet its role in prostate cancer is unkn...

    Andreas Marx, Aljoscha Schumann, Doris Höflmayer, Elena Bady in Scientific Reports (2020)

  3. Article

    Open Access

    Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer

    The role of subcellular survivin compartmentalization in the biology and prognosis of prostate cancer is unclear. We therefore investigated subcellular localization of survivin in more than 3000 prostate cance...

    Jan K. Hennigs, Sarah Minner, Pierre Tennstedt, Rolf Löser in Scientific Reports (2020)

  4. Article

    Open Access

    Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer

    Here we describe the establishment and characterization of an AR+, PSMA+, ERG+, PTEN−/−, CHD1+/− patient-derived xenograft (PDX) model termed ‘C5’, which has been developed from a 60 years old patient suffering f...

    Tobias Lange, Su Jung Oh-Hohenhorst, Simon A. Joosse, Klaus Pantel in Scientific Reports (2018)

  5. Article

    Open Access

    Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

    Asmus Heumann, Özge Kaya, Christoph Burdelski, Claudia Hube-Magg in Scientific Reports (2018)

  6. Article

    Open Access

    Mitochondrial mutations drive prostate cancer aggression

    Nuclear mutations are well known to drive tumor incidence, aggression and response to therapy. By contrast, the frequency and roles of mutations in the maternally inherited mitochondrial genome are poorly unde...

    Julia F. Hopkins, Veronica Y. Sabelnykova, Joachim Weischenfeldt in Nature Communications (2017)

  7. Article

    Open Access

    Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    Y-box binding protein 1 (YB-1) is an RNA and DNA binding factor with potential prognostic cancer. To evaluate the clinical impact of YB-1, a tissue microarray with 11,152 prostate cancers was analysed by immun...

    Asmus Heumann, Özge Kaya, Christoph Burdelski, Claudia Hube-Magg in Scientific Reports (2017)

  8. Article

    Open Access

    Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients

    The relevance of blood-based assays to monitor minimal residual disease (MRD) in non-metastatic prostate cancer (PCa) remains unclear. Proving that clinically relevant circulating tumor cells (CTCs) can be det...

    Andra Kuske, Tobias M. Gorges, Pierre Tennstedt, Anne-Kathrin Tiebel in Scientific Reports (2016)